International Journal of Radiation Oncology*Biology*Physics, found detection rates "compared favorably to the published historical controls using fluciclovine or even PSMA on conventional PET/CT scanners.""/> International Journal of Radiation Oncology*Biology*Physics, found detection rates "compared favorably to the published historical controls using fluciclovine or even PSMA on conventional PET/CT scanners.""/> Study: High-sensitivity, total body 18F-fluciclovine PET/CT scans show potential in prostate cancer

Study: High-sensitivity, total body 18F-fluciclovine PET/CT scans show potential in prostate cancer

2021-10-28

A study found high-sensitivity total-body PET/CT imaging using 18F-fluciclovine may have a role in detecting biochemically recurrent prostate cancer, researchers reported at the 2021 American Association for Radiation Oncology Annual Meeting. The single-institution study, which was published in the International Journal of Radiation Oncology*Biology*Physics, found detection rates "compared favorably to the published historical controls using fluciclovine or even PSMA on conventional PET/CT scanners."

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.